Page 97 - IJB-7-4
P. 97

Zhang, et al.
           than in the C group, suggesting that a higher extent of   3.4. The scaffolds loaded with growth factors
           signaling cascade was activated during the chondrogenic   promoted osteochondral regeneration in vivo
           differentiation of BMSCs over the C+TGF-β group than
           C group.                                            To investigate whether the composite constructs stimulate
               Furthermore,  to  investigate  the  osteogenic   osteochondral regeneration in vivo, regenerative efficacy
           differentiation of BMSCs in the bone layer, the expression   was  further  observed  in  a  rabbit  osteochondral  defect
           levels of COL I, RUNX2, OCN, and ALP were measured   model. No deaths occurred during the whole observational
           by RT-PCR (Figure  6A-D).  The  result  showed  that   period. The grafts were sampled 3 months after operation.
           mRNA expression levels of COL I, RUNX2, and OCN     The gross macroscopic observations suggested that the
           for B+BMP-2 group were obviously higher than those for   regenerated  tissues  of  the  PB  and  GB  groups  seemed
           B group after culture for 14 days. The mRNA expression   smooth  and  similar  to  the  surrounding  normal  tissues
           levels  of ALP  did  not  differ  significantly  between  the   (Figure 7A). The defects of the PB and GB groups were
           B+BMP-2 group and the B group at day 7. On the other   completely covered with excellent integration, whereas
           hand, the expression of ALP in the B+BMP-2 group was   the  repaired  tissues of the  control  group only  partially
           significantly higher than that in the B group at day 14. As   filled the defect and showed incomplete integration with
           a transcription factor, RUNX2 is expressed to activate   the native cartilage tissues.
           the expression of bone-related gene (COL I, OCN, and    Histological  and  immunohistochemical  staining
           ALP). The activation and expression of RUNX2 peak in   analyses  were  conducted  to  evaluate  repair  efficacy.
           the early stage of osteogenic differentiation of BMSCs .   Compared  to  the  control  group  and  PB  group,  the  GB
                                                        [11]
           The  RT-PCR  suggested  that  the  RUNX2  expression   group had smoother and more homogeneous neocartilage
           level  showed  no  significantly  difference  at  the  2  time   which  had  a  considerable  number  of  typical  cartilage
           points. Meanwhile, the RUNX2 transcription level was   lacunae structures (Figure 7B). The cells in neocartilage
           significantly higher in the B+BMP-2 group than in the   of  GB  group  were  in  a  typical  linear  arrangement  and
           B group at days 7 and 14, indicating that a higher extent   similar to normal chondrocytes. Masson (blue staining)
           of signaling cascade was activated during the osteogenic   and safranin O (red staining) staining were carried out
           differentiation of BMSCs in the B+BMP-2 group than   to evaluate the proportion of collagen and proteoglycan
           in the B group. The result indicated that the B+BMP-2   content, respectively (Figure 7C and D). Compared to
           constructs were able to enhance osteoinductive abilities   other groups, the collagen and proteoglycan deposition in
           in vitro.                                           the neocartilage of GB group was abundant and uniform.


                        A                                     B












                        C                                    D
















           Figure 6. mRNA expression level of bone-related genes, including (A) collagen type I (COL I, a fibrotic marker gene), (B) RUNX family
           transcription factor 2 (RUNX2), (C) osteocalcin (OCN), and (D) alkaline phosphatase (ALP) in bone layer group (B group) and cartilage
           layer loaded with BMP-2 group (B+BMP-2 group) on days 7 and 14 (n = 3; *P < 0.05).

                                       International Journal of Bioprinting (2021)–Volume 7, Issue 4        93
   92   93   94   95   96   97   98   99   100   101   102